Caffeine Increases Maximal Fat Oxidation During Exercise in Endurance-trained Men: is There a Diurnal Variation

March 24, 2020 updated by: Jonatan Ruiz Ruiz, Universidad de Granada

Maximal fat oxidation during exercise (MFO) and the intensity of exercise that elicits MFO (Fatmax) has been recognized as potential determinants of endurance performance.

The purpose of this study was to determine the possible interaction between the effects of diurnal variation (morning vs. afternoon) and caffeine ingestion on MFO, Fatmax and VO2 max in endurance-trained men. Specifically, the investigators sought to elucidate whether the stimulant actions of caffeine could reverse the decrements of MFO and Fatmax observed in the morning.

Study Overview

Detailed Description

Body weight, height, body composition (DXA), exercise test (MFO and VO2max assessment) will be measured during the 4 evaluations.

Participants were randomized into 4 exercise test conditions:

  1. Exercise test in the morning with placebo intake
  2. Exercise test in the evening with placebo intake
  3. Exercise test in the morning with caffeine intake
  4. Execrise test in the evening with caffeine intake

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Granada, Spain, 18016
        • Instituto Mixto Universitario Deporte Salud

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Having a body mass index (BMI) ranged from 18.5 to 28 kg/m2
  • not suffering any specific disease which can be aggravated by physical exercise
  • having previous experience in endurance training (i.e. self-reporting at least 2 years of cycling or running training including more than 3 training sessions/week).
  • Participant must be capable and willing to provide consent, understand exclusion criteria, instructions and protocols.

Exclusion Criteria:

  • Being smoker
  • Taking medication or drugs
  • Any non-controlled medical condition which could influence results or could be worsened by the participation in the study
  • Are deemed unsuitable by the investigator for any other reason, that prevent data collection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Caffeine
A dose of 3 mg/kg of caffeine (i.e. a vegetable extraction from green coffee beans, Harrison Sport Nutrition®, Spain) was ingested before the beginning of each test.
The exercise test was performed between 8 a.m and 11 a.m
Other Names:
  • MFO-morning, Fatmax-morning, and VO2max-morning
The exercise test was performed between 5 p.m. and 8 p.m.a
Other Names:
  • (MFO-afternoon, Fatmax-afternoon, and VO2max-afternoon
Placebo Comparator: Placebo
A dose of 3 mg/kg of placebo (i.e. 100% purity microcrystalline cellulose, Acofarma, Spain) was ingested before the beginning of each test.
The exercise test was performed between 8 a.m and 11 a.m
Other Names:
  • MFO-morning, Fatmax-morning, and VO2max-morning
The exercise test was performed between 5 p.m. and 8 p.m.a
Other Names:
  • (MFO-afternoon, Fatmax-afternoon, and VO2max-afternoon

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MFO
Time Frame: Through study completion, an average of 1 month
Maximal fat oxidation during exercise
Through study completion, an average of 1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FATmax
Time Frame: Through study completion, an average of 1 month
The intensity of exercise that elicits MFO
Through study completion, an average of 1 month
VO2max
Time Frame: Through study completion, an average of 1 month
Cardiorrespiratory fitness measured by maximal oxygen uptake
Through study completion, an average of 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jonatan Ruiz Ruiz, Dr., Universidad de Granada

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2019

Primary Completion (Actual)

November 30, 2019

Study Completion (Actual)

November 30, 2019

Study Registration Dates

First Submitted

March 19, 2020

First Submitted That Met QC Criteria

March 24, 2020

First Posted (Actual)

March 25, 2020

Study Record Updates

Last Update Posted (Actual)

March 25, 2020

Last Update Submitted That Met QC Criteria

March 24, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • Nº 507/CEIH/2018

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Athletic Performance

Clinical Trials on Test in the morning

Subscribe